Research map: Evaluation of 9-Minute Dual-Energy Peak Time–Reduced 360° CZT Total-Body [ 177 Lu]Lu-PSMA SPECT/CT Imaging with Comparisons to [ 68 Ga]Ga-PSMA PET

Back to the article

Papers in this map

  1. PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial · James Patrick Buteau · 2022 · 292 citations · Cited by this paper
  2. Sub–0.5-mm Resolution PET Versus Autoradiography: Comparison of mGluR1 Concentrations in Mouse Brain · 2026 · Related
  3. EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands · Katarina Sjögreen Gleisner · 2022 · 262 citations · Cited by this paper
  4. First-in-Human Imaging Results of PHAROS: A Versatile High-Resolution TOF/DOI PET Scanner for Brain, Breast, and Extremity Imaging · 2026 · Related
  5. Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617 · Justin Ferdinandus · 2020 · 166 citations · Cited by this paper
  6. Neuroinflammatory PET in Epilepsy: Prospects for Epileptogenic Zone Localization and Presurgical Planning · 2026 · Related
  7. Radiation Dosimetry in 177Lu-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors · Price A Jackson · 2019 · 143 citations · Cited by this paper
  8. Treatment of Human Glioblastoma Multiforme in NRG Mice by Convection-Enhanced Delivery of EGFR-Targeted or Nontargeted Auger Electron–Emitting 197g Hg-Labeled Gold Nanoparticles · 2026 · Related
  9. Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0): an international multicenter study · Andrei Gafita · 2022 · 143 citations · Cited by this paper
  10. Preoperative Assessment of Peritoneal Carcinomatosis with [ 68 Ga]Ga-FAPI-46 PET/CT: Agreement with Surgicopathologic PCI and Comparison with MRI and [ 18 F]FDG PET/CT · 2026 · Related
  11. 177 Lu-PSMA SPECT Quantitation at 6 Weeks (Dose 2) Predicts Short Progression-Free Survival for Patients Undergoing 177 Lu-PSMA-I&T Therapy · Nikeith John · 2022 · 77 citations · Cited by this paper
  12. Industry–Academic Collaboration in Nuclear Medicine: Proceedings from the 2024 CMIIT Industry Partners Circle · 2026 · Related
  13. Improving quantitative dosimetry in 177Lu-DOTATATE SPECT by energy window-based scatter corrections · Robin de Nijs · 2014 · 74 citations · Cited by this paper
  14. Translational Theranostics in Glioblastoma: FAPI-46 as a Precision Medicine Tool · 2026 · Related
  15. Evaluation of177Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN) · Sarennya Pathmanandavel · 2022 · 67 citations · Cited by this paper
  16. [ 18 F]FDG PET/MRI in Pediatric Focal Epilepsies · 2026 · Related
  17. Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry · Andreas Rinscheid · 2020 · 60 citations · Cited by this paper
  18. Radiation-Induced Senescence in Radiopharmaceutical Therapy: Mechanisms and Therapeutic Implications · 2026 · Related
  19. SPECT at the speed of PET: a feasibility study of CZT-based whole-body SPECT/CT in the post 177Lu-DOTATATE and 177Lu-PSMA617 setting · HONG SUK SONG · 2023 · 51 citations · Cited by this paper
  20. Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE Registry · 2026 · Related
  21. Patient outcomes following a response biomarker-guided approach to treatment using 177Lu-PSMA-I&T in men with metastatic castrate-resistant prostate cancer (Re-SPECT) · Louise Emmett · 2023 · 42 citations · Cited by this paper
  22. Quantitative 177Lu SPECT/CT imaging for personalized dosimetry using a ring-shaped CZT-based camera · Rachele Danieli · 2023 · 40 citations · Cited by this paper
  23. Early response monitoring during [177Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study · Moritz C. Neubauer · 2023 · 37 citations · Cited by this paper
  24. Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer · HONG SUK SONG · 2024 · 25 citations · Cited by this paper
  25. Performance study of a 360° CZT camera for monitoring 177Lu-PSMA treatment · Laure Vergnaud · 2023 · 24 citations · Cited by this paper
  26. Feasibility of 177Lu Therapy Monitoring Using Fast Whole-Body SPECT Recordings Provided by a High-Speed 360° CZT Camera · Elodie Chevalier · 2020 · 20 citations · Cited by this paper
  27. Quantitative imaging for 177Lu-PSMA treatment response monitoring and dosimetry · Catherine A.L. Meyer · 2023 · 19 citations · Cited by this paper
  28. SPECT/CT in Early Response Assessment of Patients with Metastatic Castration-Resistant Prostate Cancer Receiving177Lu-PSMA-617 · Ridvan Arda Demirci · 2024 · 13 citations · Cited by this paper
  29. Ultra-fast whole-body bone tomoscintigraphies achieved with a high-sensitivity 360° CZT camera and a dedicated deep-learning noise reduction algorithm · Achraf Bahloul · 2023 · 12 citations · Cited by this paper
  30. Assessment of [ 177 Lu]Lu-DOTATATE Dosimetry from High-Speed Whole-Body Recordings Provided by a 360° Cadmium–Zinc–Telluride Camera Compared with Results from a Conventional Anger-Camera Protocol · Timothée Zaragori · 2025 · 10 citations · Cited by this paper
  31. 177Lu-PSMA Treatment Monitoring Through Serial Fast Whole-Body Tomoscintigraphies Recorded With a Latest-Generation CZT-Camera · Caroline Boursier · 2023 · 6 citations · Cited by this paper
  32. Prognostic Value of Comprehensive Analysis of Metastatic Prostate Tumor Changes from First to Last [ 177 Lu]Lu-PSMA Therapy Injections Through Serial High-Speed Whole-Body 360° Cadmium–Zinc–Telluride SPECT · Julien Kunsch · 2025 · 3 citations · Cited by this paper

Source: OpenAlex (CC0)